Competition

In a recently published press release, the White House announced new actions to promote competition in health care and support lowering prescription drug costs for American families, including the release of a proposed framework for agencies on the exercise of march-in rights on taxpayer-funded drugs and other inventions, which specifies that price can be a factor in considering whether a drug is accessible to the public. This press release details new action to support lowering prescription drug costs and increase Americans’ access to life-saving medications, efforts to stop anticompetitive mergers and anticompetitive practices by dominant corporations in health care markets, and ...